pipecuronium has been researched along with Coronary Heart Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barankay, A | 1 |
| Thomson, IR | 1 |
2 other study(ies) available for pipecuronium and Coronary Heart Disease
| Article | Year |
|---|---|
Circulatory effects of pipecurium bromide during anaesthesia of patients with severe valvular and ischaemic heart diseases.
Topics: Androstane-3,17-diol; Androstanols; Anesthesia; Blood Gas Analysis; Cardiac Output; Coronary Disease; Electrocardiography; Extracorporeal Circulation; Heart Valve Diseases; Hemodynamics; Humans; Neuromuscular Blocking Agents; Pipecuronium; Piperazines; Preanesthetic Medication; Time Factors; Vascular Resistance | 1980 |
Are "clean" muscle relaxants better?
Topics: Anesthetics; Blood Pressure; Cardiac Output; Coronary Disease; Drug Interactions; Heart; Heart Rate; Humans; Myocardial Ischemia; Narcotics; Neuromuscular Nondepolarizing Agents; Norepinephrine; Pancuronium; Pipecuronium | 1994 |